Nathan Gardner, PA-C, CPAAPA; Abimbola Farinde, PhD, PharmD

All articles by Nathan Gardner, PA-C, CPAAPA; Abimbola Farinde, PhD, PharmD

The FDA has approved Entresto for the treatment of heart failure.

SGLT2 receptor blockers  for diabetes 

By

Nathan Gardner, PA-C, CPAAPA; Abimbola Farinde, PhD, PharmD

September 6, 2015

SGLT2 receptor blockers are only approved for type 2 diabetes.

Next post in Consultations

Pregnant women are at higher risk of anemia, particularly during the 2nd and 3rd trimesters, when the amount of blood in the body increases by 20% to 30%. Many pregnant women lack sufficient amounts of iron and other vitamins to produce adequate amounts of hemoglobin, so clinicians may prescribe an iron supplement. Women who are significantly anemic during pregnancy are at greater risk for preterm labor, can lose significant amounts of blood during delivery and are at greater risk for infection.

Can Taking Iron Pills Elevate Liver Enzymes?